| Literature DB >> 19151778 |
M L De Marchis1, M Ballarino, B Salvatori, M C Puzzolo, I Bozzoni, A Fatica.
Abstract
In the acute promyelocytic leukemia (APL) bearing the t(15;17), all-trans-retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. We identified miR-342 as one of the microRNAs (miRNAs) upregulated by ATRA during APL differentiation. This miRNA emerged as a direct transcriptional target of the critical hematopoietic transcription factors PU.1 and interferon regulatory factor (IRF)-1 and IRF-9. IRF-1 maintains miR-342 at low levels, whereas the binding of PU.1 and IRF-9 in the promoter region following retinoic ATRA-mediated differentiation, upregulates miR-342 expression. Moreover, we showed that enforced expression of miR-342 in APL cells stimulated ATRA-induced differentiation. These data identified miR-342 as a new player in the granulocytic differentiation program activated by ATRA in APL.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19151778 DOI: 10.1038/leu.2008.372
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528